Article

Effect of Apolipoprotein E ε4 on the association between health behaviors and cognitive function in late midlife

INSERM, U1018 Centre for Research in Epidemiology & Population Health, Hopital Paul Brousse, 16 avenue Paul Vaillant Couturier, Bâtiment 15/16, F-94807, Villejuif, France. .
Molecular Neurodegeneration (Impact Factor: 5.29). 06/2010; 5:23. DOI: 10.1186/1750-1326-5-23
Source: PubMed

ABSTRACT The extent to which the effect of risk factors on cognitive ageing is dependent on APOE epsilon4 remains unclear. The objective of this study is to examine whether APOE epsilon4 allele modifies the association between health behaviors and cognition in late midlife. Data are drawn from 5447 participants of the Whitehall II study, health behaviors were assessed in 1997-1999 (mean age = 55.6, Standard Deviation (SD) = 6.0) and APOE genotype and cognitive function in 2002-2004 (mean age = 60.9, SD = 5.9). Among APOE epsilon4 non-carriers, current smokers had lower scores on memory (difference in T-score = -2.49, 95%CI: -3.37, -1.60), reasoning (-2.88, 95%CI: -3.74, -2.01), phonemic (-2.66, 95%CI: -3.56, -1.76) and semantic (-2.38, 95%CI: -3.28, -1.47) fluency compared to never smokers. In APOE epsilon4 carriers, difference between current and never smokers was seen only for reasoning (-1.92, 95%CI: -3.31, -0.51). Interaction terms supported differential effects of smoking as a function of APOE epsilon4 status for memory (p = 0.01), and phonemic (p = 0.008) and semantic fluency (p = 0.02). Cognitive scores were lower among non-drinkers compared to moderate drinkers, among the sedentary participants and those who ate fruits and vegetable less than 2 times per day irrespective of APOE epsilon4 status. This study suggests that the APOE epsilon4 allele modifies the association of smoking but not that of other health behaviors - alcohol consumption, physical activity, fruit and vegetable consumption - with cognitive function in late midlife.

Download full-text

Full-text

Available from: Archana Singh-Manoux, Jun 28, 2015
0 Followers
 · 
81 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE: APOE ε4 status has been associated with greater cortical amyloid deposition, whereas exercise has been associated with less in cognitively normal adults. The primary objective here was to examine whether physical exercise moderates the association between APOE genotype and amyloid deposition in cognitively normal adults. DESIGN: APOE genotyping data and answers to a questionnaire on physical exercise engagement over the last decade were obtained in conjunction with cerebrospinal fluid (CSF) samples and amyloid imaging with carbon 11-labeled Pittsburgh Compound B ([(11)C]PiB) positron emission tomography. Participants were classified as either low or high exercisers based on exercise guidelines of the American Heart Association. SETTING: Knight Alzheimer's Disease Research Center at Washington University, St Louis, Missouri. PARTICIPANTS: A total of 201 cognitively normal adults (135 of whom were women) aged 45 to 88 years were recruited from the Knight Alzheimer's Disease Research Center. Samples of CSF were collected from 165 participants. Amyloid imaging was performed for 163 participants. RESULTS: APOE ε4 carriers evidenced higher [(11)C]PiB binding (P < .001) and lower CSF Aβ42 levels (P < .001) than did noncarriers. Our previous findings of higher [(11)C]PiB binding (P = .005) and lower CSF Aβ42 levels (P = .009) in more sedentary individuals were replicated. Most importantly, we observed a novel interaction between APOE status and exercise engagement for [(11)C]PiB binding (P = .008) such that a more sedentary lifestyle was significantly associated with higher [(11)C]PiB binding for ε4 carriers (P = .013) but not for noncarriers (P = .20). All findings remained significant after controlling for age; sex; educational level; body mass index; the presence or history of hypertension, diabetes mellitus, heart problems, or depression; and the interval between assessments. CONCLUSION: Collectively, these results suggest that cognitively normal sedentary APOE ε4-positive individuals may be at augmented risk for cerebral amyloid deposition.
    Archives of neurology 01/2012; 69(5). DOI:10.1001/archneurol.2011.845 · 7.01 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: AimsThe aim of this study was to quantify the collective effect of common lipid-associated single nucleotide polymorphisms (SNPs) on blood lipid levels, cardiovascular risk, use of lipid-lowering medication, and risk of coronary heart disease (CHD) events.Methods and resultsAnalysis was performed in two prospective cohorts: Whitehall II (WHII; N = 5059) and the British Women's Heart and Health Study (BWHHS; N = 3414). For each participant, scores were calculated based on the cumulative effect of multiple genetic variants influencing total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG). Compared with the bottom quintile, individuals in the top quintile of the LDL-C genetic score distribution had higher LDL-C {mean difference of 0.85 [95% confidence interval, (CI) = 0.76-0.94] and 0.63 [95% CI = 0.50-0.76] mmol/l in WHII and BWHHS, respectively}. They also tended to have greater odds of having 'high-risk' status (Framingham 10-year cardiovascular disease risk >20%) [WHII: odds ratio (OR) = 1.36 (0.93-1.98), BWHHS: OR = 1.49 (1.14-1.94)]; receiving lipid-lowering treatment [WHII: OR = 2.38 (1.57-3.59), BWHHS: OR = 2.24 (1.52-3.29)]; and CHD events [WHII: OR = 1.43 (1.02-2.00), BWHHS: OR = 1.31 (0.99-1.72)]. Similar associations were observed for the TC score in both studies. The TG score was associated with high-risk status and medication use in both studies. Neither HDL nor TG scores were associated with the risk of coronary events. The genetic scores did not improve discrimination over the Framingham risk score.Conclusion At the population level, common SNPs associated with LDL-C and TC contribute to blood lipid variation, cardiovascular risk, use of lipid-lowering medications and coronary events. However, their effects are too small to discriminate future lipid-lowering medication requirements or coronary events.
    European Heart Journal 09/2012; 34(13). DOI:10.1093/eurheartj/ehs243 · 14.72 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: -Carotid intima-media thickness (CIMT), a subclinical measure of atherosclerosis, is associated with risk of coronary heart disease (CHD) events. Statins reduce progression of CIMT and CHD risk in proportion to the reduction in low-density lipoprotein cholesterol (LDL-C). However, interventions targeting triglycerides or high density lipoprotein cholesterol (HDL-C) have produced inconsistent effects on CIMT and CHD risk, making it uncertain whether such agents are ineffective for CHD prevention or whether CIMT is an inadequate marker of HDL-C or triglyceride-mediated effects. We aimed to determine the causal association between the three major blood lipid fractions and common CIMT using Mendelian randomisation (MR) analysis. METHODS AND RESULTS: -Gene scores specific for LDL-C, HDL-C and triglycerides were derived based on single nucleotide polymorphisms (SNPs) from a gene-centric array in around 5000 individuals (Cardiochip scores) and from a genome-wide association meta-analysis in over 100,000 individuals (Global Lipids Genetic Consortium (GLGC) scores). These were used as instruments in an MR analysis in two prospective cohort studies. A genetically-predicted 1 mmol/L higher LDL-C concentration was associated with a higher common CIMT by 0.03 mm (95% CI=0.01-0.04) and 0.04 mm (95% CI=0.02-0.06) based on the Cardiochip and GLGC scores, respectively. HDL-C and triglycerides were not causally associated with CIMT. CONCLUSIONS: -Our findings confirm a causal relationship between LDL-C and CIMT but not with HDL-C and triglycerides. At present, the suitability of CIMT as a surrogate marker in trials of cardiovascular therapies targeting HDL-C and triglycerides is questionable and requires further study.
    Circulation Cardiovascular Genetics 12/2012; 6(1). DOI:10.1161/CIRCGENETICS.112.963140 · 5.34 Impact Factor